Peer-reviewedCC BY-NC-NDJournal of thoracic disease
Development and internal validation of a prognostic model for cancer-specific survival in elderly patients with metastatic non-small cell lung cancer: a SEER-based study
Related
- Baseline 25-hydroxyvitamin D and progression-free survival in de novo metastatic hormone-sensitive prostate cancer: prognostic model development and external validation.
- Development and internal validation of a prognostic model for predicting periodontitis progression using clinical and behavioural factors
- Interpretable Machine Learning Prognostic Model Integrating Inflammatory-Nutritional Biomarkers for Post-Prostatectomy Biochemical Recurrence: Development, Internal Validation, and Translational Target Exploration.
- Institutional Residence Six Months After Acute Ischaemic Stroke: Prognostic Model Development, Internal Validation, and Between-Country Variation in the International Stroke Trial
- Exploratory development and internal validation of sex-specific nomograms for clinically documented short-term urinary retention during post-biopsy immobilization after percutaneous renal biopsy.
BibTeX
@article{anon2026development,
title = {{Development and internal validation of a prognostic model for cancer-specific survival in elderly patients with metastatic non-small cell lung cancer: a SEER-based study}},
journal = {Journal of thoracic disease},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13655912},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Development and internal validation of a prognostic model for cancer-specific survival in elderly patients with metastatic non-small cell lung cancer: a SEER-based study
PY - 2026
DA - 2026/08/28
JO - Journal of thoracic disease
UR - https://europepmc.org/article/PMC/PMC13655912
SN - 2072-1439
SN - 2077-6624
ER -